U.S. Ambulatory Surgical Centers Market Size & Share 2025 - 2034
Market Size by Ownership, by Surgery Type, by Specialty Type, by Service, Forecast.
Download Free PDF
Market Size by Ownership, by Surgery Type, by Specialty Type, by Service, Forecast.
Download Free PDF
Starting at: $1,950
Base Year: 2024
Companies Profiled: 15
Tables & Figures: 270
Countries Covered: 1
Pages: 135
Download Free PDF
U.S. Ambulatory Surgical Centers Market
Get a free sample of this report
U.S. Ambulatory Surgical Centers Market Size
The U.S. ambulatory surgical centers market was estimated at USD 40 billion in 2024. The market is expected to grow from USD 42 billion in 2025 to USD 57.4 billion in 2034, at a CAGR of 3.5%. This high growth is attributed to several factors including rising prevalence of chronic diseases such as cancer, favorable reimbursements and government policies, increase in number of surgical procedures, and availability of treatments at comparatively lower rates than other healthcare facilities among other factors.
U.S. Ambulatory Surgical Centers Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Opportunity
Key Players
Ambulatory surgery centers (ASCs) serve as outpatient healthcare facilities where patients can receive surgical care, including diagnostic and preventive procedures. Major healthcare providers in the industry include Tenet Health, SCA HEALTH, and AMSURG, among other players. Physicians prefer to own these facilities, which represent the largest share in the ownership model segment, as it provides them with an additional source of income beyond professional fees, making these facilities a financially attractive option compared to other healthcare settings.
The market experienced strong growth, increasing from USD 33.2 billion in 2021 to USD 37.9 billion in 2023, with a CAGR of 3.5% over the analysis period. Several factors drove this growth, including more surgical procedures being performed, the expansion of ambulatory facilities across the country, and the availability of treatments at lower costs compared to hospital settings. The Leapfrog Group reports that outpatient facilities in the U.S. perform more than 60 million surgical procedures each year. This substantial number of procedures and the healthy growth rate suggest the market will continue its upward trend.
The rising number of chronic diseases such as cancer, heart disorders, and diabetes continues to be a leading cause of disability and deaths across the country. For instance, according to the statistics reported by Centers for Disease Control and Prevention (CDC), around 60% of Americans live with at least one chronic disease, while the other 40 percent manage two or more chronic conditions. As more patients seek early diagnosis and treatment for these conditions, the industry is positioned for continued growth.
Additionally, favorable reimbursements and government policies for ambulatory surgical centers continue to drive market growth. In 2023, the U.S. Department of Defense (DoD) made significant changes to TRICARE reimbursement policies for ambulatory surgery centers (ASCs) and outpatient services at Cancer and Children's Hospitals (CCHs). This change allows TRICARE to align with Medicare's payment system for both ASCs and outpatient services at CCHs, making healthcare more accessible to patients.
Ambulatory surgery centers (ASCs) serve as outpatient healthcare facilities where patients can receive surgical care, including diagnostic and preventive procedures. These facilities provide same day care for a range of surgical procedures.
U.S. Ambulatory Surgical Centers Market Trends
The market is expected to fuel the industry growth owing to trends including shift from inpatient to outpatient settings, integration of advanced equipment and solutions in the facility and expansion of ambulatory surgical center networks in the rural areas of country.
U.S. Ambulatory Surgical Centers Market Analysis
The U.S. ambulatory surgical centers market was valued at USD 33.2 billion in 2021. The market size reached USD 37.9 billion in 2023, from USD 35.6 billion in 2022.
Based on the ownership, the market is segmented into physician only, hospital only, corporate only, physician and hospital, physician and corporate, and other ownership types. The physician only segment accounted for 59.3% of the market in 2024 as the physician-led ambulatory settings have a comparatively better alignment of clinical and financial performance and have more control in the decision making. The segment is expected to exceed USD 32 billion by 2034, growing at a CAGR of 2.9% during the forecast period. Whereas the physician and hospital ownership category is expected to grow with the highest CAGR of 5% over the forecast timeline. This growth is attributed to growing dependency and involvement of physicians in a co-management role in this ownership model.
Based on the surgery type, the U.S. ambulatory surgical centers market is segmented into ophthalmology, endoscopy, orthopedic, neurology, pain management, plastic surgery, podiatry, otolaryngology, obstetrics/gynecology, dental, and others surgery types. The ophthalmology segment accounted for the highest market share of 25.8% in 2024 owing to high demand for various ophthalmic procedures such as cataract surgery, cost-effectiveness and growing aging population.
Based on specialty type, the U.S. ambulatory surgical centers market is segmented into single specialty and multi-specialty. The single specialty segment accounted for the highest market share of 59% in 2024 as these centers focus on specific surgical areas and are favored for their high reimbursement rates and strict safety standards.
Based on service, the U.S. ambulatory surgical centers market is segmented into treatment and diagnosis. The treatment segment accounted for the highest market share of 75.7% in 2024 owing to the rising incidence of chronic disorders, availability of cost-effective treatments with supportive reimbursement schemes.
South Atlantic zone dominated the U.S. ambulatory surgical centers market with the leading market share of 26.2% in 2024.
The Pacific Central zone ambulatory surgical centers market accounted for USD 8 billion in 2024.
U.S. Ambulatory Surgical Centers Market Share
Leading companies such as Tenet Health, SCA HEALTH, and AMSURG, together hold around 17% of the market share in the fragmented U.S. ambulatory surgical centers market. Major players are adopting key strategies, including joint ventures with physicians and health systems, integration of value-based care and technology, development of new ASCs, and specialty-focused expansion.
Major ASC operators, such as Tenet (through USPI) and SCA Health, are building joint ventures with physicians and hospitals to create better alignment between clinical and financial goals. When physicians and hospitals work together, it leads to more engaged doctors, better results for patients, and stronger networks for patient referrals. These partnerships help ASCs grow their presence in key markets while building integrated healthcare networks that bring in more patients, improve negotiations with insurance companies, and foster long-term collaboration.
Further, companies such as AMSURG and Regent Surgical Health are taking a focused approach by concentrating on specific medical specialties, particularly procedures that are both common and financially viable in areas like eye care, digestive health, and orthopedics. By specializing in this manner, these surgical centers can work more efficiently, complete procedures faster, and achieve better results for their patients.
Other industry operators such as HCA Healthcare, Regent Surgical and SURGERY PARTNERS have a substantial share of the market owing to the presence of ASCs across the country, better planning with physicians and adoption of advanced equipment in the facilities.
U.S. Ambulatory Surgical Centers Market Companies
Few of the prominent players operating in the U.S. ambulatory surgical centers industry include:
SCA Health builds its ambulatory surgery center (ASC) network by collaborating with physicians and health systems. The organization enhances clinical quality, streamline operations, and integrates digital solutions while adopting value-based care approaches to deliver better patient outcomes and satisfy payer needs across medical specialties.
Tenet Health, via USPI, focuses on aggressive ASC expansion through acquisitions and physician joint ventures. It emphasizes multi-specialty centers, integration with hospital systems, and value-based care models to strengthen its national footprint and drive outpatient surgical volume growth.
AMSURG concentrates on developing single-specialty ASCs, especially in gastroenterology and ophthalmology. It pursues joint ventures with physicians, emphasizes data-driven performance improvement, and expands its footprint through de novo facilities to maintain a leading position in the outpatient surgery market.
8% market share in 2024
Collective market share in 2024 is 17%
U.S. Ambulatory Surgical Centers Industry News:
The U.S. ambulatory surgical centers market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Ownership
Market, By Surgery Type
Market, By Specialty Type
Market, By Service
The above information is provided for the following zones and states:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →